Gladstone NOW: The Campaign Join Us on the Journey ✕
16 - 30 of 116 Results Clear All
Watch Juan Carlos Izpisua Belmonte present his award-winning work during the 2022 Ogawa-Yamanaka Stem Cell Prize Ceremony
Ogawa Stem Cell Prize Stem Cells/iPSCs
Juan Carlos Izpisua Belmonte, recipient of the 2022 Ogawa-Yamanaka Stem Cell Prize, is turning back the clock on old and sick cells, with many potential benefits
Awards Ogawa Stem Cell Prize Profile Stem Cells/iPSCs
Gladstone researchers talk about the power of iPS cells in biomedical research
Stem Cells/iPSCs Cardiovascular Disease Stem Cell Core
Nob Hill Gazette—Home to 30 labs and 500 researchers, Gladstone is a hub of cutting-edge research and advances toward cures for the most devastating diseases.
Gladstone Experts Doudna Lab Greene Lab Ott Lab Srivastava Lab Weinberger Lab Yamanaka Lab Big Data CRISPR/Gene Editing Stem Cells/iPSCs
Izpisua Belmonte is recognized for his innovative work in programming cellular rejuvenation
Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCs
San Jose Mercury News—Senior Investigators Melanie Ott, MD, PhD, and Bruce Conklin, MD, recount how they used miniature balls of beating heart cells called organoids to study the effects of COVID-19 on the heart. The heart cells were derived from a person's skin cells, thanks to technology pioneered by Senior Investigator and Nobel Laureate Shinya Yamanaka, MD, PhD.
Gladstone Experts Stem Cell Core COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Conklin Lab Ott Lab Yamanaka Lab Organoids
Gladstone researchers develop robust strategy for sifting through large-scale genetic data to better understand congenital heart problems
News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Krogan Lab Pollard Lab Srivastava Lab Stem Cells/iPSCs
Removing one gene from developing heart cells suddenly makes them turn into brain cell precursors, making researchers rethink cellular identity
News Release Research (Publication) Cardiovascular Disease Bruneau Lab Stem Cells/iPSCs Hota
Gladstone researchers discover a fundamental mechanism that appears to speed the change of stem cells into other cell types
News Release Research (Publication) Virology Weinberger Lab Stem Cells/iPSCs Chaturvedi
A new human organoid developed by Gladstone scientists mimics one of the key steps in early embryonic development
News Release Research (Publication) Cardiovascular Disease McDevitt Lab CRISPR/Gene Editing Stem Cells/iPSCs
Scientists generate synthetic mouse embryos containing the three fundamental cell types normally found in pre-implantation embryos
News Release Research (Publication) iPS Cell Research Center Stem Cells/iPSCs
Steve Finkbeiner is leading key components of this unprecedented resource to boost ALS research.
Gladstone Experts ALS Center for Systems and Therapeutics Finkbeiner Lab AI Robotic Microscopy Stem Cells/iPSCs
Watch presentations from The State of Stem Cell Symposium
iPS Cell Research Center Stem Cells/iPSCs
ABC7 News—Gladstone President Deepak Srivastava, MD, a pediatric cardiologist, explains how his group discovered a potential new drug to treat a debilitating disease due to the hardening of heart valves.
Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs
Gladstone President Deepak Srivastava moderated a conversation with Jennifer Doudna and Shinya Yamanaka.
Philanthropy Doudna Lab Yamanaka Lab CRISPR/Gene Editing Stem Cells/iPSCs
